Skip to main content

The effects of diets enriched in beta-glucans on blood lipoprotein concentrations

Journal Article


Abstract


  • Dietary beta-glucans lower the blood concentrations of cholesterol in animals and humans. Recent studies have uncovered mechanisms by which dietary beta-glucans may regulate cholesterol homeostasis. There is evidence that beta-glucans sequester bile acids in the intestine, reducing their

    reabsorption and return to the liver. Reducing hepatic bile acid concentrations activates the enzyme

    CYP7A1, which converts cholesterol into bile acids. This action leads to a reduction of hepatic cell

    cholesterol content, which up-regulates low-density lipoprotein (LDL) receptor synthesis and thereby

    accelerates the transportation of LDL-cholesterol from the blood into hepatocytes. Reduced intracellular

    cholesterol also up-regulates the hepatic synthesis of 3-hydroxy-3-methylglutaryl coenzyme A reductase,

    the rate-limiting enzyme in cholesterol synthesis. Statins inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase and could therefore provide an additive effect in suppressing hepatocyte cholesterol to that produced by enhancing its depletion with beta-glucans. Through this combination of agents, one would expect a greater clearance of LDL from the plasma with lower steady state levels of LDL-cholesterol.

Publication Date


  • 2009

Citation


  • Chen, J. & Huang, X. (2009). The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. Journal of Clinical Lipidology, 3 (3), 154-158.

Scopus Eid


  • 2-s2.0-66949151765

Has Global Citation Frequency


Number Of Pages


  • 4

Start Page


  • 154

End Page


  • 158

Volume


  • 3

Issue


  • 3

Place Of Publication


  • United States

Abstract


  • Dietary beta-glucans lower the blood concentrations of cholesterol in animals and humans. Recent studies have uncovered mechanisms by which dietary beta-glucans may regulate cholesterol homeostasis. There is evidence that beta-glucans sequester bile acids in the intestine, reducing their

    reabsorption and return to the liver. Reducing hepatic bile acid concentrations activates the enzyme

    CYP7A1, which converts cholesterol into bile acids. This action leads to a reduction of hepatic cell

    cholesterol content, which up-regulates low-density lipoprotein (LDL) receptor synthesis and thereby

    accelerates the transportation of LDL-cholesterol from the blood into hepatocytes. Reduced intracellular

    cholesterol also up-regulates the hepatic synthesis of 3-hydroxy-3-methylglutaryl coenzyme A reductase,

    the rate-limiting enzyme in cholesterol synthesis. Statins inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase and could therefore provide an additive effect in suppressing hepatocyte cholesterol to that produced by enhancing its depletion with beta-glucans. Through this combination of agents, one would expect a greater clearance of LDL from the plasma with lower steady state levels of LDL-cholesterol.

Publication Date


  • 2009

Citation


  • Chen, J. & Huang, X. (2009). The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. Journal of Clinical Lipidology, 3 (3), 154-158.

Scopus Eid


  • 2-s2.0-66949151765

Has Global Citation Frequency


Number Of Pages


  • 4

Start Page


  • 154

End Page


  • 158

Volume


  • 3

Issue


  • 3

Place Of Publication


  • United States